Main Article Content

Verna Biutifasari https://orcid.org/0000-0002-4419-0868
Ellen Angelique Hardjono https://orcid.org/0009-0009-6569-9004
Ronald Pratama Adiwinoto https://orcid.org/0000-0002-2112-610X
Janto Poernomo Hadi https://orcid.org/0009-0000-3423-7696

Abstract

Systemic immune-inflammation index (SII) and prognostic nutritional index (PNI) serve as simple and practical tests that help indicate inflammatory and nutritional status to some extent. Lung cancer stands out as the most common contributor to cancer-related mortality globally. It is associated with an unfavorable prognosis. Most patients diagnosed with lung cancer have metastasis at the time of diagnosis. Prognostic heterogeneity of cancer patients causes the need for more prognostic biomarkers. This study aimed to evaluate the clinical value of SII and PNI in predicting metastasis in lung cancer patients. SII and PNI provides a prognostic value in lung cancer. Retrospective cross-sectional research was conducted in this study involving 138 data from medical records at the Inpatient and Outpatient Department of Pulmonology, RSPAL dr. Ramelan Surabaya in April 2019 to July 2023. Kolmogorov-Smirnov test, contingency coefficient test, and ROC analysis were done to analyze the data obtained. Patients with metastatic lung cancer had higher SII than those without metastasis. The group of patients with metastasis had an average SII of 5391.34 and a PNI of 40.11. The group of patients without metastasis had an average SII of 2849.52 and PNI of 43.05. Lung cancer metastasis was correlated significantly with SII but not with PNI. The cut-off value was determined using the ROC curve. The cut-off value for SII was 2198.54 (68.5% sensitivity and 58.7% specificity) and for PNI was 42.2 (62% sensitivity and 54.3% specificity). SII was correlated with lung cancer metastasis and may be a promising indicator predicting of metastasis. PNI showed no significant correlation with lung cancer metastasis.

Downloads

Download data is not yet available.

Article Details

How to Cite
Biutifasari, V., Hardjono, E. A., Adiwinoto, R. P. and Hadi, J. P. (2025) “The clinical value of systemic immune-inflammation index (SII) and prognostic nutritional index (PNI) for predicting the occurrence of metastasis in patients with lung cancer”, Indonesian Journal of Medical Laboratory Science and Technology, 7(1), pp. 31–39. doi: 10.33086/ijmlst.v7i1.5628.
Section
Articles
Systemic immune-inflammation index, Prognostic nutritional index, Lung cancer, Prognostic biomarker

References

Alexander M, Kim SY, Cheng H. Update 2020: Management of non-small cell lung cancer. Lung. 2020;198(6):897–907. https://doi.org/10.1007/s00408-020-00407-5

Mi HL, Wei WL, Zhang DH, Liang HY, Yue CF, Xu JN. Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and prognostic nutritional index as prognostic markers for lung carcinoma. Br J Hosp Med (Lond). 2024;85(10):1–13. https://doi.org/10.12968/hmed.2024.0270

Nooreldeen R, Bach H. Current and future development in lung cancer diagnosis. Int J Mol Sci. 2021;22(16):8661. https://doi.org/10.3390/ijms22168661

Li Y, Yan B, He S. Advances and challenges in the treatment of lung cancer. Biomed Pharmacother. 2023;169:115891. https://doi.org/10.1016/j.biopha.2023.115891

Qi C, Sun SW, Xiong XZ. From COPD to lung cancer: mechanisms linking, diagnosis, treatment, and prognosis. Int J Chron Obstruct Pulmon Dis. 2022;17:2603-2621. https://doi.org/10.2147/copd.s380732

Platini H, Ferdinand E, Kohar K, Prayogo SA, Amirah S, Komariah M, et al. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as prognostic markers for advanced non-small-cell lung cancer treated with immunotherapy: A systematic review and meta-analysis. Medicina (Kaunas). 2022;58(8):1069. https://doi.org/10.3390/medicina58081069

Huang W, Luo J, Wen J, Jiang M. The Relationship between systemic immune inflammatory index and prognosis of patients with non-small cell lung cancer: A meta-analysis and systematic review. Front Surg. 2022;9:898304. https://doi.org/10.3389/fsurg.2022.898304

Zhou Y, Dai M, Zhang Z. Prognostic significance of the systemic immune-inflammation index (SII) in patients with small cell lung cancer: A meta-analysis. Front Oncol. 2022;12:814727. https://doi.org/10.3389/fonc.2022.814727

Zenjaya KT, Biutifasari V, Yudadi R, Wibowo P. Systemic immune-inflammation index (SII) and neutrophil lymphocyte ratio (NLR) as a promising predictor for advanced stage events during the follow-up period in hepato-gastrointestinal cancer patients. Indones J Cancer. 2024;18(4):453–9. https://doi.org/10.33371/ijoc.v18i4.1186

Wang D, Hu X, Xiao L, Long G, Yao L, Wang Z, et al. Prognostic nutritional index and systemic immune-inflammation index predict the prognosis of patients with HCC. J Gastrointest Surg. 2021;25(2):421-427. https://doi.org/10.1007/s11605-019-04492-7

Biutifasari V, Untari NKSD, Nugraheni PA, Adiwinoto RP, Pratiknya DE, Setiawan V, et al. Hyperbaric oxygen therapy increases brain-derived neurotrophic factor as well as decreases systemic immune-inflammatory index and systemic inflammatory response index in autism spectrum disorder. Indones Biomed J. 2024;16(6):534–9. https://doi.org/10.18585/inabj.v16i6.3358

Hayasaka K, Notsuda H, Onodera K, Watanabe T, Watanabe Y, Suzuki T, et al. Prognostic value of perioperative changes in the prognostic nutritional index in patients with surgically resected non-small cell lung cancer. Surg Today. 2024;54(9):1031–40. https://doi.org/10.1007/s00595-024-02847-5

Kubota K, Ito R, Narita N, Tanaka Y, Furudate K, Akiyama N, et al. Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment. BMC Cancer. 2022;22(1):368. https://doi.org/10.1186/s12885-022-09439-x

Li L, Wang Y, Yang P, Xu L, Liu S, Zhang S, et al. Correlation of the controlling nutritional status score and the prognostic nutritional index with the prognosis of patients treated with radiotherapy for small-cell lung cancer. Ann Palliat Med. 2021;10(11):11635–42. https://doi.org/10.21037/apm-21-2740

Jiang AM, Zhao R, Liu N, Ma YY, Ren M Di, Tian T, et al. The prognostic value of pretreatment prognostic nutritional index in patients with small cell lung cancer and it’s influencing factors: A meta-analysis of observational studies. J Thorac Dis. 2020;12(10):5718–28. https://doi.org/10.21037/jtd-20-1739

Ürün M, Güner G, Sezgin Y, Uysal E, Sakin A, Kilickap S. Prognostic significance of the advanced lung cancer inflammation index in metastatic small cell lung cancer: A retrospective analysis of 96 patients. Med Sci Monit. 2024;30:e945752. https://doi.org/10.12659/msm.945752

Xia H, Zhang W, Zheng Q, Zhang Y, Mu X, Wei C, et al. Predictive value of the prognostic nutritional index in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis. Heliyon. 2023;9(8):e17400. https://doi.org/10.1016/j.heliyon.2023.e17400

Park S, Ahn HJ, Yang M, Kim JA, Kim JK, Park SJ. The prognostic nutritional index and postoperative complications after curative lung cancer resection: A retrospective cohort study. J Thorac Cardiovasc Surg. 2020;160(1):276-285.e1. https://doi.org/10.1016/j.jtcvs.2019.10.105

Zhang L, Zhao K, kuang T, Wang K, Chai D, Qiu Z, et al. The prognostic value of the advanced lung cancer inflammation index in patients with gastrointestinal malignancy. BMC Cancer. 2023;23(1):101. https://doi.org/10.1186/s12885-023-10570-6

Fest J, Ruiter R, Mulder M, Groot Koerkamp B, Ikram MA, Stricker BH, et al. The systemic immune-inflammation index is associated with an increased risk of incident cancer—A population-based cohort study. Int J Cancer. 2020;146(3):692–8. https://doi.org/10.1002/ijc.32303

Li X, Gu L, Chen Y, Chong Y, Wang X, Guo P, et al. Systemic immune-inflammation index is a promising non-invasive biomarker for predicting the survival of urinary system cancers: a systematic review and meta-analysis. Ann Med. 2021;53(1):1827-1838. https://doi.org/10.1080/07853890.2021.1991591

Shi Y, Liu X, Liu J, Zhang D, Liu X, Yue Y, et al. Correlations between peripheral blood biomarkers and clinical outcomes in advanced non-small cell lung cancer patients who received immunotherapy-based treatments. Transl Lung Cancer Res. 2021;10(12):4477–93. https://doi.org/10.21037/tlcr-21-710

Ding P, Guo H, Sun C, Yang P, Kim NH, Tian Y, et al. Combined systemic immune-inflammatory index (SII) and prognostic nutritional index (PNI) predicts chemotherapy response and prognosis in locally advanced gastric cancer patients receiving neoadjuvant chemotherapy with PD-1 antibody sintilimab and XELOX: a prospective study. BMC Gastroenterol. 2022;22(1):121. https://doi.org/10.1186/s12876-022-02199-9

Fujii T, Tokuda S, Nakazawa Y, Kurozumi S, Obayashi S, Yajima R, et al. Implications of low serum albumin as a prognostic factor of long-term outcomes in patients with breast cancer. In Vivo (Brooklyn). 2020;34(4):2033–6. https://doi.org/10.21873/invivo.12003

Shao Y, Cao W, Gao X, Tang M, Zhu D, Liu W. The value of pretreatment prognostic nutritional index in predicting prognosis in lung cancer patients receiving immune checkpoint inhibitors-based treatment:A Systematic Review and Meta-Analysis. Medicine (Baltimore). 2022;101(43):e31113. https://doi.org/10.1097/md.0000000000031113

Verna Biutifasari, Hang Tuah University

Department of Clinical Pathology, Faculty of Medicine, Hang Tuah University, Surabaya, Indonesia

Ellen Angelique Hardjono, Hang Tuah University

Faculty of Medicine, Hang Tuah University, Surabaya, Indonesia

Ronald Pratama Adiwinoto, Hang Tuah University

Department of Public Health, Faculty of Medicine, Hang Tuah University, Surabaya, Indonesia

Janto Poernomo Hadi, Naval Center Hospital Dr. Ramelan Surabaya

Department of Pulmonology, Naval Center Hospital Dr. Ramelan Surabaya, Indonesia